Agile therapeutics reports third quarter 2023 financial results and provides corporate update

Twirla delivers third quarter 2023 net revenue of $6.7 million, a 21% increase from second quarter 2023 company announces it expects to generate positive cash flow from operations in first quarter 2024 gross margin grows to 63% in third quarter 2023 from 58% in second quarter 2023 company reaffirms expected full year 2023 net revenue of at least $25 million management to host conference call today, thursday, november 9, 2023 at 8:30 a.m. et princeton, n.j.
AGRX Ratings Summary
AGRX Quant Ranking